Table 1 Pre-treatment patient demographics
Patient demographic | Value |
|---|---|
Total patients | 20 |
Sex: number (percentage) | |
Male | 17 (85%) |
Female | 3 (15%) |
Age: (years) | |
Mean | 69 |
Range | 58–80 |
WHO performance status: number (percentage) | |
0 | 7 (35%) |
1 | 12 (60%) |
2 | 1 (5%) |
Pre-treatment CEA (μg/L): | |
Mean | 384 |
Range | 3–2897 |
Pre-treatment LDH (IU/L): | |
Mean | 2279 |
Range | 45–11,346 |
Chemotherapy regimen: number (percentage) | |
Oxaliplatin and 5FU | 18 (90%) |
Oxaliplatin and capecitabine | 2 (10%) |